• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

缺血时间因素对舒芬太尼后处理减轻大鼠心肌缺血再灌注损伤效应的影响

Effects of ischemic time factors on reduction of myocardial ischemia-reperfusion injury by sulfentanil postconditioning in rats

摘要目的:评价缺血时间因素对舒芬太尼后处理减轻大鼠心肌缺血再灌注损伤效应的影响。方法雄性SD大鼠,体重230~250 g ,采用Langendorff灌注装置制备离体心脏灌注模型。取离体心脏48个,平衡灌注30 min ,采用随机数字表法,将其分为6组( n=8):I/R1-3组分别心肌缺血30、45和60 min ,再灌注90 min;SP1-3组分别心肌缺血30、45和60 min ,再灌注90 min ,并于再灌注15 min时K-H液中加入100 nmol/L舒芬太尼行后处理。分别于平衡灌注末、再灌注15、30、60和90 min时,记录左室舒张末压(LVEDP)、左室发展压(LVDP)、左室内压最大上升和最大下降速率(± dp/dtmax )、HR和冠脉流量(CF )。再灌注5 min时,收集冠脉流出液,测定肌酸激酶(CK )及乳酸脱氢酶(LDH )的活性。再灌注90 min时,每组取5个心脏,测定心肌梗死体积。结果与平衡灌注末比较,I/R1-3组再灌注各时点LVEDP升高,LVDP、± dp/dtmax和CF均降低( P<0.05);与I/R1组和I/R2组比较,I/R3组再灌注30、60和90 min时LVEDP升高,LVDP及± dp/dtmax降低,再灌注15和30 min时HR和CF降低,冠脉流出液CK、LDH的活性、心肌梗死体积升高,SP1组和SP2组再灌注30、60和90 min时LVEDP降低,LVDP、± dp/dtmax和CF升高,冠脉流出液CK和LDH的活性、心肌梗死体积降低( P<0.05);与I/R3组比较,SP3组再灌注30、60和90 min时LVDP降低( P<0.05),冠脉流出液CK和LDH的活性、心肌梗死体积差异无统计学意义( P>0.05)。结论缺血30和45 min时舒芬太尼后处理可减轻大鼠心肌缺血再灌注损伤,而缺血60 min时舒芬太尼后处理无心肌保护作用。

更多

abstractsObjective To evaluate the effects of ischemic time factors on reduction of myocardial ischemia-reperfusion injury by sulfentanil postconditioning in rats .Methods Healthy adult male Sprague-Dawley rats ,weighing 230-250 g ,were heparinized and anesthetized with intraperitoneal 5% chloral hydrate 8 ml/kg .The hearts were excised and perfused in a Langendorff apparatus with K-H solution .After 30 min of stabilization ,48 isolated rat hearts were randomly assigned into 6 groups (n=8 each) using a random number table .In I/R1-3 groups ,the hearts were subjected to 30 ,45 ,and 60 min of myocardial ischemia ,respectively ,followed by 90 min of reperfusion . In SP1-3 groups , the hearts were subjected to 30 , 45 , and 60 min of myocardial ischemia , respectively ,followed by 90 min of reperfusion ,and sulfentanil 100 nmol/L was added to K-H solution at 15 min of reperfusion for postconditioning . Left ventricular end-diastolic pressure (LVEDP ) , left ventricular developed pressure (LVDP) ,+dp/dtmax ,-dp/dtmax ,HR and coronary flow (CF) were measured at the end of equilibration and 15 ,30 ,60 and 90 min of reperfusion .Creatine kinase (CK) and lactate dehydrogenase (LDH) activities in coronary effluent were measured at 5 min of reperfusion .Myocardial infarct size was determined in 5 hearts chosen&nbsp;randomly at 90 min of reperfusion .Results LVEDP was significantly higher ,and LVDP , ± dp/dtmax and CF were lower at each time point of reperfusion than at the end of equilibration in I/R1-3 groups ( P<0.05) .Compared with I/R1 and I/R2 groups ,LVEDP was significantly increased ,and LVDP and ± dp/dtmax were decreased at 30 ,60 and 90 min of reperfusion ,HR and CF were decreased ,and CK and LDH activities in coronary effluent and infarct size were increased at 15 and 30 min of reperfusion in group I/R3 ,and LVEDP was significantly decreased ,LVDP , ± dp/dtmax and CF were increased ,CK and LDH activities in coronary effluent and infarct size were decreased at 30 , 60 and 90 min of reperfusion in groups SP1 and SP2 ( P< 0.05 ) . Compared with group I/R3 , LVDP was significantly decreased at 30 ,60 and 90 min of reperfusion ( P<0.05) ,and no significant change was found in CK and LDH activities in coronary effluent and infarct size in group SP3 ( P>0.05 ) .Conclusion Sulfentanil postconditioning can attenuate myocardial ischemia-reperfusion injury when the rats are subjected to 30 or 45 min of ischemia ,however ,it provides no myocardial protection when the rats are subjected to 60 min of ischemia .

More
广告
  • 浏览259
  • 下载56
中华麻醉学杂志

中华麻醉学杂志

2014年3期

341-344页

ISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷